Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (12)

2024

  1. Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression

    Cancers, Vol. 16, Núm. 4

  2. Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle

    Cancer Letters, Vol. 585

  3. Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype

    Frontiers in Cellular and Infection Microbiology, Vol. 14

  4. Metal-based nanoparticles in cancer therapy: Exploring photodynamic therapy and its interplay with regulated cell death pathways

    International Journal of Pharmaceutics, Vol. 649

  5. Metastatic outgrowth via the two-way interplay of autophagy and metabolism

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 3

  6. The obesity-autophagy-cancer axis: Mechanistic insights and therapeutic perspectives

    Seminars in Cancer Biology, Vol. 99, pp. 24-44

  7. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

    Cell Communication and Signaling, Vol. 22, Núm. 1

2023

  1. Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery

    European Journal of Pharmacology, Vol. 958

  2. Correction to: Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective (Cell & Bioscience, (2023), 13, 1, (44), 10.1186/s13578-023-00986-9)

    Cell and Bioscience

  3. Editorial: Autophagy modulation in cancer treatment utilizing nanomaterials and nanocarriers

    Frontiers in Oncology

  4. Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective

    Cell and Bioscience, Vol. 13, Núm. 1

2022

  1. Sirtuins and Hypoxia in EMT Control

    Pharmaceuticals, Vol. 15, Núm. 6